The role of melatonin on miRNAs modulation in triple-negative breast cancer cells
Open Access
- 3 February 2020
- journal article
- research article
- Published by Public Library of Science (PLoS) in PLOS ONE
- Vol. 15 (2) , e0228062
Abstract
Melatonin, a hormone secreted by pineal gland, exerts antimetastatic effects by reducing tumor cell proliferation, migration and invasion. MicroRNAs (miRNAs) are small, non-coding RNAs that play a crucial role in regulation of gene expression and biological processes of the cells. Herein, we search for a link between the tumor/metastatic-suppressive actions of melatonin and miRNA expression in triple-negative breast cancer cells. We demonstrated that melatonin exerts its anti-tumor actions by reducing proliferation, migration and c-Myc expression of triple negative breast cancer cells. By using Taqman-based assays, we analyzed the expression levels of a set of miRNAs following melatonin treatment of triple negative breast cancer cells and we identified 17 differentially expressed miRNAs, 6 down-regulated and 11 up-regulated. We focused on the anti-metastatic miR-148b and the oncogenic miR-210 both up-regulated by melatonin treatment and studied the effect of their modulation on melatonin-mediated impairment of tumor progression. Surprisingly, when miR-148b or miR-210 were depleted in triple-negative breast cancer cells, using a specific miR-148b sponge or anti-miR-210, melatonin effects on migration inhibition and c-myc downregulation were still visible suggesting that the increase of miR-148b and miR-210 expression observed following melatonin treatment was not required for the efficacy of melatonin action. Nevertheless, ours results suggest that melatonin exhibit a compound for metastatic trait inhibition, especially in MDA-MB-231 breast cancer cells even if a direct link between modulation of expression of certain proteins or miRNAs and melatonin effects has still to be established.Keywords
Funding Information
- FAPESP (2015/04780-6)
This publication has 46 references indexed in Scilit:
- Melatonin, a Full Service Anti-Cancer Agent: Inhibition of Initiation, Progression and MetastasisInternational Journal of Molecular Sciences, 2017
- Melatonin Represses Metastasis inHer2-Postive Human Breast Cancer Cells by Suppressing RSK2 ExpressionMolecular Cancer Research, 2016
- MiR-148b suppresses cell proliferation and invasion in hepatocellular carcinoma by targeting WNT1/β-catenin pathwayScientific Reports, 2015
- Melatonin modulation of crosstalk among malignant epithelial, endothelial and adipose cells in breast cancer (Review)Oncology Letters, 2014
- miR181b is induced by the chemopreventive polyphenol curcumin and inhibits breast cancer metastasis via down‐regulation of the inflammatory cytokines CXCL1 and ‐2Molecular Oncology, 2014
- MicroRNA and gene expression analysis of melatonin-exposed human breast cancer cell lines indicating involvement of the anticancer effectJournal of Pineal Research, 2011
- Basic Mechanisms Involved in the Anti-Cancer Effects of MelatoninCurrent Medicinal Chemistry, 2010
- MicroRNA miR-210 modulates cellular response to hypoxia through the MYC antagonist MNTCell Cycle, 2009
- miRNAs, Cancer, and Stem Cell DivisionCell, 2005
- Differential regulation of estrogen receptor alpha, glucocorticoid receptor and retinoic acid receptor alpha transcriptional activity by melatonin is mediated via different G proteinsJournal of Pineal Research, 2004